1. |
杨晓妍, 吴先萍. 2型糖尿病危险因素研究进展. 预防医学情报杂志, 2001, 17(1): 12-13.
|
2. |
Sun H, Saeedi P, Karuranga S, et al. IDF diabetes atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract, 2022, 183: 109119.
|
3. |
Chen JF, Zhang YP, Han JX, et al. Systematic evaluation of the prevalence of cognitive impairment in elderly patients with diabetes in China. Clin Neurol Neurosurg, 2023, 225: 107557.
|
4. |
Ding X, Yin L, Zhang L, et al. Diabetes accelerates Alzheimer's disease progression in the first year post mild cognitive impairment diagnosis. Alzheimers Dement, 2024, 20(7): 4583-4593.
|
5. |
Pal K, Mukadam N, Petersen I, et al. Mild cognitive impairment and progression to dementia in people with diabetes, prediabetes and metabolic syndrome: a systematic review and meta-analysis. Soc Psychiatry Psychiatr Epidemiol, 2018, 53(11): 1149-1160.
|
6. |
国家老年医学中心, 中华医学会老年医学分会, 中国老年保健协会糖尿病专业委员会, 等. 中国老年糖尿病诊疗指南(2024版). 协和医学杂志, 2024, 15(4): 771-800.
|
7. |
中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2020年版)(上). 中国实用内科杂志, 2021, 41(8): 668-695.
|
8. |
Moons KG, de Groot JA, Bouwmeester W, et al. Critical appraisal and data extraction for systematic reviews of prediction modelling studies: the CHARMS checklist. PLoS Med, 2014, 11(10): e1001744.
|
9. |
Moons KGM, Wolff RF, Riley RD, et al. PROBAST: a tool to assess risk of bias and applicability of prediction model studies: explanation and elaboration. Ann Intern Med, 2019, 170(1): W1-W33.
|
10. |
Wolff RF, Moons KGM, Riley RD, et al. PROBAST: a tool to assess the risk of bias and applicability of prediction model studies. Ann Intern Med, 2019, 170(1): 51-58.
|
11. |
阚李梅, 孙莉, 张莹, 等. 血小板活化、聚集功能及LDL-C对糖尿病认知功能障碍的预测价值及其列线图模型的建立. 医学研究杂志, 2023, 52(10): 54-84.
|
12. |
张海鑫, 张一方, 谢芷兰, 等. 基于机器学习构建老年糖尿病患者轻度认知障碍风险评估模型. 中华疾病控制杂志, 2024, 28(3): 1674-3679.
|
13. |
刘敏丽, 边红艳. 2型糖尿病患者认知功能障碍风险预测模型的构建. 卫生职业教育, 2024, 42(3): 153-157.
|
14. |
王志虎. 2型糖尿病患者轻度认知障碍风险预测模型构建与验证. 天津: 天津中医药大学, 2023.
|
15. |
张宁, 陈雁, 张红梅, 等. 2型糖尿病患者轻度认知功能障碍发生风险的Logistic回归和决策树预测模型的构建. 中国实用护理杂志, 2023, 39(32): 2514-2520.
|
16. |
张晓莉. 2型糖尿病患者轻度认知功能障碍风险预测模型的构建. 兰州: 甘肃中医药大学, 2023.
|
17. |
杨蓓, 叶红芳, 相卢伟, 等. 中老年2型糖尿病患者轻度认知障碍风险预测模型的构建与验证. 护理学报, 2024, 31(13): 18-23.
|
18. |
梁运来, 尉文泽, 侯启卓, 等. 2型糖尿病合并认知障碍临床预测指标的筛选及评估. 中华预防医学杂志, 2024, 58(8): 1184-1190.
|
19. |
Teng Z, Feng J, Xie X, et al. A nomogram including total cerebral small vessel disease burden score for predicting mild vascular cognitive impairment in patients with type 2 diabetes mellitus. Diabetes Metab Syndr Obes, 2024, 17: 1553-1562.
|
20. |
Maimaitituerxun R, Chen W, Xiang J, et al. Predictive model for identifying mild cognitive impairment in patients with type 2 diabetes mellitus: a CHAID decision tree analysis. Brain Behav, 2024, 14(3): e3456.
|
21. |
Liu Y, Zhang S, He B, et al. Periphery biomarkers for objective diagnosis of cognitive decline in type 2 diabetes patients. Front Cell Dev Biol, 2021, 9: 752753.
|
22. |
Kang H, Kim J, Kim M, et al. Prediction model for mild cognitive impairment in patients with type 2 diabetes using the autonomic function test. Neurol Sci, 2024, 45(8): 3757-3766.
|
23. |
Jiang Y, Liu X, Gao H, et al. A new nomogram model for the individualized prediction of mild cognitive impairment in elderly patients with type 2 diabetes mellitus. Front Endocrinol (Lausanne), 2024, 15: 1307837.
|
24. |
Exalto LG, Biessels GJ, Karter AJ, et al. Risk score for prediction of 10 year dementia risk in individuals with type 2 diabetes: a cohort study. Lancet Diabetes Endocrinol, 2013, 1(3): 183-190.
|
25. |
Ding Q, Yu C, Xu X, et al. Development and validation of a risk score for mild cognitive impairment in individuals with type 2 diabetes in china: a practical cognitive prescreening tool. Diabetes Metab Syndr Obes, 2024, 17: 1171-1182.
|
26. |
Yu Q, Jiang X, Yan J, et al. Development and validation of a risk prediction model for mild cognitive impairment in elderly patients with type 2 diabetes mellitus. Geriatr Nurs, 2024, 58: 119-126.
|
27. |
Li CI, Li TC, Liu CS, et al. Risk score prediction model for dementia in patients with type 2 diabetes. Eur J Neurol, 2018, 25(7): 976-983.
|
28. |
王为, 杨小华, 王姝琴, 等. 2型糖尿病并发认知功能障碍的危险因素分析及Nomogram模型构建. 皖南医学院学报, 2024, 43(3): 254-257.
|
29. |
Zhou X, Dai N, Yu D, et al. Development and validation of Galectin-3 and CVAI-based model for predicting cognitive impairment in type 2 diabetes. J Endocrinol Invest, 2025, 48(4): 1017-1031.
|
30. |
Zhang J, Tam WWS, Lu J, et al. Cognitive risk stratification score in middle-aged and older adults with type 2 diabetes: a cross-sectional study. J Clin Endocrinol Metab, 2025, dgaf063.
|
31. |
Rajkomar A, Dean J, Kohane I. Machine learning in medicine. N Engl J Med, 2019, 380(14): 1347-1358.
|
32. |
莫航沣, 陈亚萍, 韩慧, 等. 临床预测模型研究方法与步骤. 中国循证医学杂志, 2024, 24(2): 228-236.
|
33. |
Steyerberg EW, Harrell FE, Borsboom GJ, et al. Internal validation of predictive models: efficiency of some procedures for logistic regression analysis. J Clin Epidemiol, 2001, 54(8): 774-781.
|
34. |
Altman DG, Royston P. The cost of dichotomising continuous variables. BMJ, 2006, 332(7549): 1080.
|
35. |
Zhang Q, Wang L. Abstract: evaluating methods for moderation analysis with missing data in the predictors. Multivariate Behav Res, 2015, 50(1): 144-145.
|
36. |
Collins GS, Reitsma JB, Altman DG, et al. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. BMJ, 2015, 350: g7594.
|
37. |
许汝福. Logistic回归变量筛选及回归方法选择实例分析. 中国循证医学杂志, 2016, 16(11): 1360-1364.
|
38. |
Whalley LJ, Deary IJ, Appleton CL, et al. Cognitive reserve and the neurobiology of cognitive aging. Ageing Res Rev, 2004, 3(4): 369-382.
|
39. |
Logroscino G, Kang JH, Grodstein F. Prospective study of type 2 diabetes and cognitive decline in women aged 70-81 years. BMJ, 2004, 328(7439): 548.
|
40. |
Katon W, Lyles CR, Parker MM, et al. Association of depression with increased risk of dementia in patients with type 2 diabetes: the diabetes and aging study. Arch Gen Psychiatry, 2012, 69(4): 410-417.
|
41. |
李代钦, 黄永清. 抑郁症对于认知影响因素. 临床医学进展, 2022, 12(5): 4105-4109.
|
42. |
Xue M, Xu W, Ou YN, et al. Diabetes mellitus and risks of cognitive impairment and dementia: A systematic review and meta-analysis of 144 prospective studies. Ageing Res Rev, 2019, 55: 100944.
|
43. |
Lin CH, Sheu WH. Hypoglycaemic episodes and risk of dementia in diabetes mellitus: 7-year follow-up study. J Intern Med, 2013, 273(1): 102-110.
|
44. |
Fanelli CG, Porcellati F, Pampanelli S, et al. Insulin therapy and hypoglycaemia: the size of the problem. Diabetes Metab Res Rev, 2004, 20(Suppl 2): 32-42.
|
45. |
Alba AC, Agoritsas T, Walsh M, et al. Discrimination and calibration of clinical prediction models: users' guides to the medical literature. JAMA, 2017, 318(14): 1377-1384.
|
46. |
Mandrekar JN. Receiver operating characteristic curve in diagnostic test assessment. J Thorac Oncol, 2010, 5(9): 1315-1316.
|